Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healios KK Ord Shs HLOSF

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.


PINL:HLOSF - Post by User

Post by The300on Feb 09, 2011 6:28pm
537 Views
Post# 18105518

Cleaning up the market

Cleaning up the marketI believe today was a very good sign that the Halo market is being cleared of overhang.

There has been alot of conjecture on this forum that Dwek/Mineralfields has been providing most of the selling pressure which brought us down to $.40.

If that is true, I would imagine that Cannacord coming into the market to cross out 400,000 shares was likely clearing out part of Mineralfields position.

It makes complete sense to cross out Mineralfields, assuming they are agreeable to it, as Mineralfields gets to move out large blocks at a better price than if they were just selling in the open market, and on the flip side, Halo and its shareholders don't have to bare the brunt of the selling pressure.

Either way, the market looks much better today than it has in a while.  Bids are building, and asks are being pulled.

Hopefully this is a sign of things to come.

As always, the above is my humble opinion.

Regards,

The 300
<< Previous
Bullboard Posts
Next >>